J. Carlson

发表

Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching

P. Garhyan, F. Zhao, H. Detke, 2011, International clinical psychopharmacology.

A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.

D. Jeste, J. Carlson, P. Cavazzoni, 2006, The Journal of clinical psychiatry.

The safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials.

R. Dittmann, J. Carlson, L. Kryzhanovskaya, 2009, The Journal of clinical psychiatry.

Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse

R. Switzer, G. Ellison, Janice Carlson, 2000, Neuropharmacology.

Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.

E. Dunayevich, S. Marder, R. Baker, 2010, The Journal of clinical psychiatry.

Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics

O. Osuntokun, B. Millen, J. Carlson, 2011, Journal of psychopharmacology.

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.

C. McDougle, M. Tohen, J. Frazier, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Olanzapine versus placebo in adolescents with schizophrenia

C. McDougle, M. Tohen, J. Frazier, 2007 .

Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus

G. Ellison, K. Noguchi, Janice Carlson, 2001, Brain Research.

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double‐blind, placebo‐controlled studies

J. Erickson, J. Davidson, M. Pollack, 2008, Human psychopharmacology.